treatment-resistant-depression
Articles tagged with “treatment-resistant-depression”
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
Five anonymized clinical case studies illustrating treatment outcomes with low-dose ketamine across treatment-resistant depression, PTSD, chronic pain, and bipolar depression, with detailed dosing, timelines, and clinical lessons.
IV Racemic Ketamine vs Esketamine (Spravato): A Clinical Comparison
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
Ketamine vs TMS (Transcranial Magnetic Stimulation): Two Approaches to Treatment-Resistant Depression
Evidence-based comparison of ketamine therapy and transcranial magnetic stimulation (TMS) for treatment-resistant depression, examining mechanisms, treatment protocols, efficacy, side effects, FDA approval status, cost, and convenience.
Ketamine for Depression
Frequently asked questions about using low-dose ketamine to treat depression, including how it works, response rates, speed of onset, and maintenance strategies.
Ketamine for Depression: A Comprehensive Evidence-Based Guide
An in-depth clinical guide examining the evidence for low-dose ketamine in the treatment of major depressive disorder and treatment-resistant depression. Covers mechanisms of action, clinical trial data, response predictors, duration of effect, maintenance strategies, and cost-benefit analysis.
Ketamine vs Traditional Antidepressants: Mechanism, Efficacy, and Clinical Role
Comprehensive comparison of ketamine therapy versus traditional antidepressants (SSRIs, SNRIs, TCAs) for depression, covering onset of action, mechanisms, efficacy in treatment-resistant depression, side effects, cost, and access.
IV vs Oral Ketamine: Routes of Administration Compared
Clinical comparison of intravenous and oral ketamine for depression and pain, examining bioavailability, efficacy evidence, convenience, cost, monitoring requirements, and appropriate clinical settings.
Low-Dose Ketamine for Treatment-Resistant Depression
An evidence-based overview of low-dose ketamine as a rapidly acting antidepressant for patients with treatment-resistant depression, including mechanisms of action, clinical protocols, and outcome data.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.